Sign inGet started

Trevejo Jose M.

Insider CIK 1661539 · TARS Chief Medical Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
TARS Tarsus Pharmaceuticals, In S Sale2023-12-202023-12-222,252$20.00 $45.0K2,251SEC↗
TARS Tarsus Pharmaceuticals, In S Sale2023-10-052023-10-061,604$18.00 $28.9K4,503SEC↗
TARS Tarsus Pharmaceuticals, In S Sale2023-03-232023-03-23465$12.15 $5.6K6,107SEC↗
TARS Tarsus Pharmaceuticals, In S Sale2023-03-222023-03-23529$12.64 $6.7K6,572SEC↗
TARS Tarsus Pharmaceuticals, In S Sale2023-03-212023-03-23519$12.89 $6.7K7,101SEC↗
TARS Tarsus Pharmaceuticals, In S Sale2023-03-202023-03-21530$12.61 $6.7K7,620SEC↗
TARS Tarsus Pharmaceuticals, In S Sale2023-03-172023-03-21504$13.28 $6.7K8,150SEC↗
TARS Tarsus Pharmaceuticals, In S Sale2023-03-162023-03-17499$13.43 $6.7K8,654SEC↗
TARS Tarsus Pharmaceuticals, In M Exercise deriv2023-03-152023-03-177,549— $022,648SEC↗
TARS Tarsus Pharmaceuticals, In M Exercise2023-03-152023-03-177,549— $09,153SEC↗
TARS Tarsus Pharmaceuticals, In A Award deriv2023-03-082023-03-1030,792— $030,792SEC↗
TARS Tarsus Pharmaceuticals, In A Award deriv2023-03-082023-03-1045,459— $045,459SEC↗
TARS Tarsus Pharmaceuticals, In A Award deriv2022-02-012022-02-0330,197— $030,197SEC↗
TARS Tarsus Pharmaceuticals, In A Award deriv2022-02-012022-02-03116,424— $0116,424SEC↗